Type 2 & other diabetes

Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial

Diabetes MetabPublished Secondary analysis of the CORDIOPREV randomised controlled trial

Authors' conclusion

Our study showed that lowering circulating AGE levels, specifically MG, after following a Mediterranean diet, might be linked to the preservation of kidney function, evidenced by a decreased decline of eGFR in T2DM patients with CHD. Patients with mildly decreased eGFR could potentially benefit more from AGE reduction in maintaining kidney function.

Study context

Population
T2D patients with coronary heart disease and estimated glomerular filtration rate (eGFR) ≥ 30 ml/min/1.73 m², classified by baseline kidney function: normal eGFR (≥ 90), mildly decreased (60- < 90) and moderately decreased (<60 ml/min/1.73 m²)of 1002 in CORDIOPREV
Participants
540 patients
Comparison
Mediterranean diet vs low-fat diet
Primary endpoint
eGFR decline
Follow-up
5-years of dietary intervention

Primary result

As reported in the abstract

5 years
  • Lower eGFR decline with Mediterranean diet vs low-fat diet only in patients with mildly decreased eGFR
  • Mediterranean diet vs Low-fat diet: P = 0.035

Further findings

Methylglyoxal (MG) levels and GloxI expression in normal and mildly decreased eGFR

Mediterranean diet decreased MG levels and increased GloxI expression in normal and mildly decreased eGFR patients
all P < 0.05

Association of MG levels after intervention with eGFR decline

Per 1 SD increment of MG levels after intervention, probability of eGFR decline
6.8-fold higher (95 % CI 0.039;0.554)

Original publication

Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial. Diabetes Metab. Published 12 December 2023. doi:10.1016/j.diabet.2023.101503

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.